BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22693617)

  • 21. Uromodulin-associated kidney disease.
    Bleyer AJ; Zivná M; Kmoch S
    Nephron Clin Pract; 2011; 118(1):c31-6. PubMed ID: 21071970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel uromodulin mutation in familial juvenile hyperuricemic nephropathy.
    Wei X; Xu R; Yang Z; Li Z; Liao Y; Johnson RJ; Yu X; Chen W
    Am J Nephrol; 2012; 36(2):114-20. PubMed ID: 22776760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequencing of LRP2 reveals multiple rare variants associated with urinary trefoil factor-3.
    McMahon GM; Olden M; Garnaas M; Yang Q; Liu X; Hwang SJ; Larson MG; ; Goessling W; Fox CS
    J Am Soc Nephrol; 2014 Dec; 25(12):2896-905. PubMed ID: 24876117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TCF7L2 variants associate with CKD progression and renal function in population-based cohorts.
    Köttgen A; Hwang SJ; Rampersaud E; Coresh J; North KE; Pankow JS; Meigs JB; Florez JC; Parsa A; Levy D; Boerwinkle E; Shuldiner AR; Fox CS; Kao WH
    J Am Soc Nephrol; 2008 Oct; 19(10):1989-99. PubMed ID: 18650481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion.
    Troyanov S; Delmas-Frenette C; Bollée G; Youhanna S; Bruat V; Awadalla P; Devuyst O; Madore F
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):62-9. PubMed ID: 26683887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unveiling the Hidden Power of Uromodulin: A Promising Potential Biomarker for Kidney Diseases.
    Thielemans R; Speeckaert R; Delrue C; De Bruyne S; Oyaert M; Speeckaert MM
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel UMOD mutations in familial juvenile hyperuricemic nephropathy lead to abnormal uromodulin intracellular trafficking.
    Liu M; Chen Y; Liang Y; Liu Y; Wang S; Hou P; Zhang H; Zhao M
    Gene; 2013 Dec; 531(2):363-9. PubMed ID: 23988501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies.
    Kottgen A; Kao WH; Hwang SJ; Boerwinkle E; Yang Q; Levy D; Benjamin EJ; Larson MG; Astor BC; Coresh J; Fox CS
    BMC Med Genet; 2008 Jun; 9():49. PubMed ID: 18522750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of Urinary Uromodulin with Clinical Characteristics and Markers of Tubular Function in the General Population.
    Pruijm M; Ponte B; Ackermann D; Paccaud F; Guessous I; Ehret G; Pechère-Bertschi A; Vogt B; Mohaupt MG; Martin PY; Youhanna SC; Nägele N; Vollenweider P; Waeber G; Burnier M; Devuyst O; Bochud M
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):70-80. PubMed ID: 26683888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An intermediate-effect size variant in
    Olinger E; Schaeffer C; Kidd K; Elhassan EAE; Cheng Y; Dufour I; Schiano G; Mabillard H; Pasqualetto E; Hofmann P; Fuster DG; Kistler AD; Wilson IJ; Kmoch S; Raymond L; Robert T; ; Eckardt KU; Bleyer AJ; Köttgen A; Conlon PJ; Wiesener M; Sayer JA; Rampoldi L; Devuyst O
    Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2114734119. PubMed ID: 35947615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary UMOD excretion and chronic kidney disease in gout patients: cross-sectional case-control study.
    Wu CH; Lee CT; Lee CH; Cheng TT; Chang HW; Lin E; Chuang FR; Yang HP; Chen YC; Wu CY; Chen CJ
    Ren Fail; 2011; 33(2):164-8. PubMed ID: 21332338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uromodulin to Osteopontin Ratio in Deceased Donor Urine Is Associated With Kidney Graft Outcomes.
    Mansour SG; Liu C; Jia Y; Reese PP; Hall IE; El-Achkar TM; LaFavers KA; Obeid W; Rosenberg AZ; Daneshpajouhnejad P; Doshi MD; Akalin E; Bromberg JS; Harhay MN; Mohan S; Muthukumar T; Schröppel B; Singh P; El-Khoury JM; Weng FL; Thiessen-Philbrook HR; Parikh CR
    Transplantation; 2021 Apr; 105(4):876-885. PubMed ID: 32769629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of uromodulin as a new serum marker to predict decline in renal function.
    Leiherer A; Muendlein A; Saely CH; Brandtner EM; Geiger K; Fraunberger P; Drexel H
    J Hypertens; 2018 Jan; 36(1):110-118. PubMed ID: 28858977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide association study of kidney function decline in individuals of European descent.
    Gorski M; Tin A; Garnaas M; McMahon GM; Chu AY; Tayo BO; Pattaro C; Teumer A; Chasman DI; Chalmers J; Hamet P; Tremblay J; Woodward M; Aspelund T; Eiriksdottir G; Gudnason V; Harris TB; Launer LJ; Smith AV; Mitchell BD; O'Connell JR; Shuldiner AR; Coresh J; Li M; Freudenberger P; Hofer E; Schmidt H; Schmidt R; Holliday EG; Mitchell P; Wang JJ; de Boer IH; Li G; Siscovick DS; Kutalik Z; Corre T; Vollenweider P; Waeber G; Gupta J; Kanetsky PA; Hwang SJ; Olden M; Yang Q; de Andrade M; Atkinson EJ; Kardia SL; Turner ST; Stafford JM; Ding J; Liu Y; Barlassina C; Cusi D; Salvi E; Staessen JA; Ridker PM; Grallert H; Meisinger C; Müller-Nurasyid M; Krämer BK; Kramer H; Rosas SE; Nolte IM; Penninx BW; Snieder H; Fabiola Del Greco M; Franke A; Nöthlings U; Lieb W; Bakker SJ; Gansevoort RT; van der Harst P; Dehghan A; Franco OH; Hofman A; Rivadeneira F; Sedaghat S; Uitterlinden AG; Coassin S; Haun M; Kollerits B; Kronenberg F; Paulweber B; Aumann N; Endlich K; Pietzner M; Völker U; Rettig R; Chouraki V; Helmer C; Lambert JC; Metzger M; Stengel B; Lehtimäki T; Lyytikäinen LP; Raitakari O; Johnson A; Parsa A; Bochud M; Heid IM; Goessling W; Köttgen A; Kao WH; Fox CS; Böger CA
    Kidney Int; 2015 May; 87(5):1017-29. PubMed ID: 25493955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of known estimated glomerular filtration rate loci in patients with type 2 diabetes.
    Deshmukh HA; Palmer CN; Morris AD; Colhoun HM
    Diabet Med; 2013 Oct; 30(10):1230-5. PubMed ID: 23586973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common variants of the UMOD promoter associated with blood pressure in a community-based Chinese cohort.
    Han J; Chen Y; Liu Y; Liang Y; Wang X; Liu L; Wang F; Zhang L; Zhang H; Wang H
    Hypertens Res; 2012 Jul; 35(7):769-74. PubMed ID: 22592667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UMOD as a susceptibility gene for end-stage renal disease.
    Reznichenko A; Böger CA; Snieder H; van den Born J; de Borst MH; Damman J; van Dijk MC; van Goor H; Hepkema BG; Hillebrands JL; Leuvenink HG; Niesing J; Bakker SJ; Seelen M; Navis G;
    BMC Med Genet; 2012 Sep; 13():78. PubMed ID: 22947327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease.
    Rampoldi L; Scolari F; Amoroso A; Ghiggeri G; Devuyst O
    Kidney Int; 2011 Aug; 80(4):338-47. PubMed ID: 21654721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a common UMOD variant on kidney function, blood pressure, cognitive and physical function in a community-based cohort of older adults.
    Villagomez Fuentes LE; Algharably EA; Toepfer S; König M; Demuth I; Bertram L; Kreutz R; Bolbrinker J
    J Hum Hypertens; 2022 Nov; 36(11):983-988. PubMed ID: 34593962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single nucleotide polymorphism in the UMOD promoter is associated with end stage renal disease.
    Chen T; Wang Q; Li G; Wang L
    BMC Med Genet; 2016 Dec; 17(1):95. PubMed ID: 27938332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.